Search

Objective:Erectile dysfunction (ED) has a significant impact on quality of life, given its high prevalence and association with cardiovascular diseases. In the present study, we aimed to evaluate exercise treadmill parameters in patients with ED.Methods:A total of 178 patients who were admitted to the cardiology clinic was enrolled in the study. Patients were divided into two groups according to their International Index of Erectile Function-5 (IIEF-5) score. Exercise time, maximum heart rate (HR), resting HR, chronotropic index (CI), HR recovery at one minute (HRR1) and two minutes (HRR2) were evaluated for each patient.Results:Subjects with ED were older, had similar rates of diabetes mellitus and hypertension compared to control group. Exercise time was longer and peak HR was higher in patients with ED compared to the healthy counterparts [556.00 (61) sec. vs 575.5 (84) sec. p=0.025, and 156.00 (13) bpm vs 160.50 (11) bpm p=0.001, respectively]. We did not find statistically significant differences with respect to resting HR, HRR1, HRR2, CI, maximum systolic and diastolic blood pressure, or rate pressure product between two groups. IIEF-5 score was negatively correlated with age (r=-0.54, p=

Background: The AnTicoagulation and Risk factors in Atrial fibrillation (ATRIA) and CHA2DS2VASc risk scores used to detect the thromboembolic and hemorrhagic risk in atrial fibrillation (AF) patients has been shown recently to predict poor clinical outcomes varies clinical settings, regardless of having AF. We aimed to examine the potential utility of admission CHA2DS2VASc and ATRIA scores for predicting in-hospital mortality in patients with coronavirus disease 2019 (COVID-19). Methods: In this retrospective study hospitalized 134 COVID-19 patients who diagnosed with a positive polymerase chain reaction test, were included. Patients were divided into two groups who were died and survivors, both the groups were compared according to clinical, laboratory, and demographic features, including the CHA2DS2VASc and ATRIA risk score. Predictors of mortality were determined by logistic regression analysis. Results: ATRIA and CHA2DS2VASc risk scores were predicting mortality in COVID-19 patients. Logistic regression analysis showed that ATRIA risk score, AF and chronic obstructive pulmonary disease were an independent predictor of mortality. For an ATRIA score cut off value of 3, the sensitivity was 77.78%, specificity 57.94%, positive predictive value 31.80, and negative predictive value 91.20. For a CHA2DS2VASc score cut-off value of 4, the sensitivity was 44.44%, specificity 83.18%, positive predictive value 40, and negative predictive value 85.60. Conclusion: CHA2DS2-VASc and ATRIA scores can be used as a novel, simple tool for predicting mortality in COVID-19 patients.

The novel COVID-19-related disorders have become a global health problem since the pandemic emerged in China. Herein, we present a case of late pulmonary embolism development after successful COVID-19 treatment. A 45-year-old male was admitted to the emergency department with shortness of breath. He was diagnosed with mild COVID-19 pneumonia 10 days ago which was treated with hydroxychloroquine and oseltamivir for 5 days. He did not receive anticoagulation during this period. His second polymerase chain reaction test for COVID-19 came negative at the day before the second admission. He was diagnosed with pulmonary embolism and received anticoagulation therapy with heparin. COVID-19-related complications appear to still happen after treatment. Hence, follow-up of these patients is essential in order to reduce the burden of COVID-19. Thromboprophylaxis is certainly required during hospitalization. Moreover, the duration of thromboprophylaxis may be extended in some patients.